Celldex Therapeutics, Inc. Profile Avatar - Palmy Investing

Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflamma…

Biotechnology
US, Hampton [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
Marucci Anthony S
PRESIDENT & CEO
Also inside the BofD
11/12/24 [Form 4]
Martin Samuel Bates
SVP AND CFO
06/18/24 [Form 4]
Crowley Elizabeth
SR. VP & CPDO
06/18/24 [Form 4]
Jimenez Freddy A.
SVP & GENERAL COUNSEL
06/17/24 [Form 4]
Young Diane C.
SVP, CHIEF MEDICAL OFFICER
06/17/24 [Form 4]
Heath-Chiozzi Margo
SVP OF REGULATORY AFFAIRS
06/17/24 [Form 4]
Cavanaugh Sarah
SVP OF CORP AFFAIRS & ADMIN.
06/17/24 [Form 4]
Wright Richard M.
SR. VP & CCO
06/17/24 [Form 4]
Pepin Ronald
SR. VP & CBO
06/17/24 [Form 4]
Keler Tibor
EXECUTIVE VP & CSO
06/17/24 [Form 4]
End of CLDX's Analysis
CIK: 744218 CUSIP: 15117B202 ISIN: US15117B2025 LEI: - UEI: -
Secondary Listings
CLDX has no secondary listings inside our databases.